Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Feb;89(2):171-6. doi: 10.1067/moe.2000.101810.

Abstract

Objective: Orofacial granulomatosis and the oral manifestations of Crohn's disease comprise many clinical features, of which stomatitis is one. The purpose of this study was to establish a role for Staphylococcus aureus in mucositis affecting some patients with orofacial granulomatosis or oral Crohn's disease.

Study design: Four patients (2 with orofacial granulomatosis and 2 with oral Crohn's disease), from a total of 450 patients examined over 10 years, had stomatitis involving the entire oral mucosa, from which S aureus was cultured by the oral rinse technique. These patients were treated with flucloxacillin or erythromycin.

Results: A heavy growth of S aureus was isolated from the mouth of each patient. All 4 patients responded to treatment with flucloxacillin or erythromycin.

Conclusions: S aureus is a potential cause of panstomatitis in patients with orofacial granulomatosis or Crohn's disease. This infection responds rapidly to antimicrobial treatment.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Crohn Disease / complications*
  • Erythromycin / therapeutic use
  • Face
  • Female
  • Floxacillin / therapeutic use
  • Granuloma / complications*
  • Humans
  • Male
  • Mouth Mucosa / microbiology*
  • Penicillins / therapeutic use
  • Staphylococcal Infections / complications*
  • Staphylococcal Infections / drug therapy
  • Staphylococcus aureus / isolation & purification
  • Stomatitis / drug therapy
  • Stomatitis / etiology
  • Stomatitis / microbiology*

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • Floxacillin
  • Erythromycin